Our professionals

Imagen del Dr. Bruno Paiva, investigador de Hematología de la Clínica Universidad de Navarra

Dr. Bruno Paiva

Researcher in the Hematology and Hemotherapy Department at Clínica Universidad de Navarra.
Co-Director of the Hemato-Oncology Program.
Principal Investigator of the Translational Immunomics in Hematologic Neoplasms group.
Director of the Flow Cytometry Platform.
Primary focus on multidimensional flow cytometry analysis of hematologic neoplasms.

Be part of: Cima Universidad de Navarra Clínica Universidad de Navarra Cancer Center Clínica Universidad de Navarra
INDEX H 66

Professional career

PharmD (Pharmacy degree), University of Coimbra, Portugal (2007).

PhD in Biology and Cancer Clinical Science, Faculty of Medicine, University of Salamanca (2011). 

RESEARCH AREAS

  • Principal Investigator on more than 20 national and international projects.
  • Has established numerous scientific collaboration frameworks with several pharmaceutical and biotechnology companies. 

AREAS OF INTEREST

  • Differential diagnosis and follow-up of hematologic neoplasms, with a particular interest in multiple myeloma and acute myeloblastic leukemia.

Activity

In teaching

  • Assistant Professor (tenure-track) in the Hematology Teaching Unit, Faculty of Medicine, University of Navarra. Since 2022-2023.

In research

  • With 17 years of research experience, he has contributed to more than 200 publications, serving as first author on more than 40 and as last author and/or corresponding author on more than 40. These include papers in leading journals such as N Engl J Med, Nat Med, Cancer Cell, Lancet Oncol, and J Clin Oncol, with notable numbers in top hematology journals (Blood, more than 40) and oncology journals (J Clin Oncol, more than 10). More than 95% of his publications are in the Q1 quartile of their respective fields.
Imagen de un icono azul con un documento certificado.

Acknowledgments

I have been awarded with numerous recognitions, including the Bart Barlogie Young Investigator Award for outstanding research developed in multiple myeloma, and The Future Leaders in Hematology Award of the 2015 Celgene Awards for Clinical Research in Haematology.